Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akero Therapeutics, Inc. | Chief Financial Officer | Common Stock | 41.2K | $1.08M | $26.18 | Sep 10, 2024 | Direct |
Disc Medicine, Inc. | Director | Common Stock | 0 | $0 | $58.94 | Nov 4, 2024 | Direct |
Ventyx Biosciences, Inc. | Director | Stock Option (Right to Buy) | 33K | Jun 6, 2024 | Direct | ||
Akero Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 24.7K | Aug 27, 2024 | Direct | ||
Disc Medicine, Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IRON | Disc Medicine, Inc. | Nov 1, 2024 | 8 | -$99.5K | 4 | Nov 5, 2024 | Director |
IRON | Disc Medicine, Inc. | Oct 1, 2024 | 6 | -$8.33K | 4 | Oct 3, 2024 | Director |
AKRO | Akero Therapeutics, Inc. | Sep 10, 2024 | 1 | -$16.7K | 4 | Sep 13, 2024 | Chief Financial Officer |
IRON | Disc Medicine, Inc. | Sep 3, 2024 | 8 | -$90.5K | 4 | Sep 5, 2024 | Director |
AKRO | Akero Therapeutics, Inc. | Aug 26, 2024 | 12 | -$1.07M | 4 | Aug 29, 2024 | Chief Financial Officer |
IRON | Disc Medicine, Inc. | Aug 1, 2024 | 4 | -$6.75K | 4 | Aug 5, 2024 | Director |
AKRO | Akero Therapeutics, Inc. | Jul 23, 2024 | 11 | -$3.25M | 4 | Jul 25, 2024 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Jul 16, 2024 | 4 | -$767K | 4 | Jul 18, 2024 | Chief Financial Officer |
IRON | Disc Medicine, Inc. | Jul 1, 2024 | 5 | -$7.27K | 4 | Jul 3, 2024 | Director |
IRON | Disc Medicine, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
AKRO | Akero Therapeutics, Inc. | Jun 11, 2024 | 1 | -$64.1K | 4 | Jun 13, 2024 | Chief Financial Officer |
VTYX | Ventyx Biosciences, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
IRON | Disc Medicine, Inc. | Jun 3, 2024 | 7 | -$64K | 4 | Jun 5, 2024 | Director |
IRON | Disc Medicine, Inc. | May 1, 2024 | 4 | -$3.77K | 4 | May 3, 2024 | Director |
IRON | Disc Medicine, Inc. | Apr 11, 2024 | 6 | -$68.8K | 4 | Apr 15, 2024 | Director |
AKRO | Akero Therapeutics, Inc. | Mar 13, 2024 | 1 | -$20.5K | 4 | Mar 15, 2024 | Chief Financial Officer |
VTYX | Ventyx Biosciences, Inc. | Jan 21, 2024 | 1 | $0 | 4 | Jan 23, 2024 | Director |
AKRO | Akero Therapeutics, Inc. | Dec 14, 2023 | 1 | -$12.7K | 4 | Dec 18, 2023 | Chief Financial Officer |
IRON | Disc Medicine, Inc. | Dec 12, 2023 | 10 | -$1.91M | 4 | Dec 14, 2023 | Director |
AKRO | Akero Therapeutics, Inc. | Dec 8, 2023 | 2 | $0 | 4 | Dec 12, 2023 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Nov 9, 2023 | 1 | $0 | 4 | Nov 13, 2023 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Sep 13, 2023 | 1 | -$31.8K | 4 | Sep 25, 2023 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Jun 20, 2023 | 3 | -$1.02M | 4 | Jun 22, 2023 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Jun 13, 2023 | 1 | -$33.4K | 4 | Jun 15, 2023 | Chief Financial Officer |
IRON | Disc Medicine, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
VTYX | Ventyx Biosciences, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
AKRO | Akero Therapeutics, Inc. | Mar 10, 2023 | 1 | -$27.9K | 4 | Mar 14, 2023 | Chief Financial Officer |
VTYX | Ventyx Biosciences, Inc. | Jan 23, 2023 | 5 | -$969K | 4 | Jan 24, 2023 | Director |
IRON | Disc Medicine, Inc. | Dec 29, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Director |
IRON | Disc Medicine, Inc. | Dec 29, 2022 | 0 | $0 | 3 | Jan 3, 2023 | Director |
AKRO | Akero Therapeutics, Inc. | Dec 27, 2022 | 6 | -$855K | 4 | Dec 29, 2022 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Dec 16, 2022 | 1 | $0 | 4 | Dec 20, 2022 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Dec 9, 2022 | 2 | $0 | 4 | Dec 13, 2022 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Oct 13, 2022 | 3 | -$656K | 4 | Oct 17, 2022 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Sep 13, 2022 | 4 | -$651K | 4 | Sep 15, 2022 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Sep 9, 2022 | 3 | $9.25K | 4 | Sep 13, 2022 | Chief Financial Officer |
VTYX | Ventyx Biosciences, Inc. | Jun 9, 2022 | 1 | $0 | 4/A | Apr 26, 2023 | Director |
AKRO | Akero Therapeutics, Inc. | Jan 14, 2022 | 3 | -$146K | 4 | Jan 18, 2022 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Dec 21, 2021 | 3 | -$1.5K | 4 | Dec 23, 2021 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Dec 17, 2021 | 3 | -$48.1K | 4 | Dec 20, 2021 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Dec 8, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Nov 1, 2021 | 3 | -$99K | 4 | Nov 3, 2021 | Chief Financial Officer |
VTYX | Ventyx Biosciences, Inc. | Oct 20, 2021 | 0 | $0 | 3 | Oct 20, 2021 | Director |
AKRO | Akero Therapeutics, Inc. | Oct 1, 2021 | 3 | -$97.8K | 4 | Oct 5, 2021 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Sep 1, 2021 | 3 | -$145K | 4 | Sep 3, 2021 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Aug 2, 2021 | 3 | -$66.7K | 4 | Aug 4, 2021 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Jul 6, 2021 | 3 | -$114K | 4 | Jul 8, 2021 | Chief Financial Officer |